Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Szema AM et al. - Biotechnology in the form of novel but currently available and in-practice medical devices, as well as new therapeutic agents, have expanded the armamentarium for safely managing patients with HAE pre- and intraoperatively.

Related Articles

Human C1-Esterase Inhibitor Concentrate (Berinert(R))
BioDrugs, 11/10/09    Relevance Score: 87%

Anaphylaxis and angioedema
Dermatology in Practice, 10/09/09    Relevance Score: 87%

Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency
Journal of Allergy and Clinical Immunology, 10/07/09    Relevance Score: 87%

Supraglottic swelling may not correlate with tongue swelling in angiotensin converting enzyme inhibitor-induced angioedema
The Laryngoscope, 11/06/09    Relevance Score: 84%

Pathogenesis and laboratory diagnosis of hereditary angioedema
Allergy and Asthma Proceedings, 10/09/09    Relevance Score: 84%

Today in Derm Allergy/Immunology...keeping you current

Failure of omalizumab in cholinergic urticaria
Clinical and Experimental Dermatology, 11/25/09

Granulomatous Dermatitis With Pseudoxanthoma Elasticum-Like Changes
Archives of Dermatology, 11/25/09

Schnitzlers syndrome with prominent neutrophil infiltration misdiagnosed as Sweets syndrome: a typical example of urticarial neutrophilic dermatosis
Clinical and Experimental Dermatology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address